Publication: A rare case of ectopic ACTH syndrome caused by primary renal neuroendocrine tumor
Issued Date
2021-01-01
Resource Type
ISSN
20520573
Other identifier(s)
2-s2.0-85105403739
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Endocrinology, Diabetes and Metabolism Case Reports. Vol.2021, No.1 (2021)
Suggested Citation
Paweena Chunharojrith, Kanapon Pradniwat, Tanawan Kongmalai A rare case of ectopic ACTH syndrome caused by primary renal neuroendocrine tumor. Endocrinology, Diabetes and Metabolism Case Reports. Vol.2021, No.1 (2021). doi:10.1530/EDM-20-0076 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78752
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A rare case of ectopic ACTH syndrome caused by primary renal neuroendocrine tumor
Other Contributor(s)
Abstract
Ectopic adrenocorticotropic hormone (ACTH) secretion is responsible for 5-15% of Cushing’s syndrome (CS). Neuroendocrine tumor (NET) is a common cause of ectopic ACTH syndrome (EAS). However, primary renal NET is exceedingly rare. Fewer than 100 cases have been reported and only a few cases presented with CS. Because of its rarity and lack of long-term follow-up data, clinical manifestations, biological behavior and prognosis are not well understood. Here, we report the case of a 51-year-old man who presented with clinical and laboratory findings compatible with EAS. CT scan revealed a lesion of uncertain nature at the lower pole of the left kidney. Octreotide scan found a filling defect at the lower pole of left kidney. It was difficult to determine if this finding was the true etiology or an incidental finding. Unfortunately, the patient’s clinical status rapidly deteriorated with limited medical treatment. The patient underwent left nephrectomy and left adrenalectomy. Histopathological examination confirmed NET with oncocytic features. Immunohistochemistry staining was positive for ACTH. The patient’s condition gradually improved. Additionally, glucocorticoid replacement was required only 6 months during a gradual recovery of hypothalamic pituitary adrenal axis achieved approximately three years after tumor removal. Although extremely rare, primary renal NET should be considered as a cause of EAS particularly in a patient with rapid clinical deterioration. Thorough investigation, early diagnosis and careful management are crucial to reduce morbidity and mortality.